Concomitantly, we found that the expression level of CXCR2, the cognate receptor of CXCL5, was highly expressed at both mRNA and protein levels in inflamed LEC-CM treated CCA cells. The gene discussed is CXCR2; the disease is cholangiocarcinoma.